The α-Cot-NK92 cells with ZEGFR/α-HER2-Cot recognized and lysed tumor cells depending on EGFR/HER2 surface expression levels in various tissue-derived cancer cell lines including AU565, SK-OV-3, A431, and A549 cells. This evidence concerns the gene ERBB2 and cancer.